ALB and tuberculosis: Therefore, factors such as age, types of drugs affecting the QT interval, and serum albumin should be considered when developing a DR-TB treatment regimen to fully assess the benefits and risks of the regimen in order to ensure the safety of patients and improve the tolerability and safety of the regimen.